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Chopped human nasal polyps and bronchial tissue produced lipoxin A., and isomers of lipoxins 4 and B4, but not lipoxin B,, after incubation 
with exogenous leukotriene 4. In addition, these tissues transformed arachidonic acid to 15hydroxyeicosatetraenoic acid. The capacity per gram 
of tissue to produce lipoxins and IS-hydroxyeicosatetraenoic acid was 3-S-times higher in the nasal polyps. Neither tissue produced detectable 
levels of lipoxins or leukotrienes after incubation with ionophore A23187 and arachidonic acid. Co-incubation of nasal polyps and polymorphonuc- 
lear granulocytes with ionophore A23187 led to the formation of lipoxins, including lipoxins A., and B4. The results indicate the involvement of 
an epithelial 15-lipoxygenase in lipoxin formation in human airways. 
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1. INTRODUCTION 
Metabolism of arachidonic acid by 5, 12- and 
1Slipoxygenases leads to formation of the correspon- 
ding hydroperoxyeicosatetraenoic acids (HPETE), 
which are reduced to hydroxyeicosatetraenoic acids 
(HETE). Alternatively, SHPETE may be converted to 
an unstable epoxide intermediate, leukotriene (LT)&, 
which is further metabolized to the biologically active 
leukotrienes B4, Cd, D4 and Es (for review see [l]). 
Leukotriene A4 is not only a key intermediate in the 
formation of leukotrienes, but is also converted to 
lipoxins. Thus, we have recently described lipoxin pro- 
duction from endogenous ources of arachidonic acid 
via platelet-dependent lipoxygenation at C-l 5 of 
granulocyte-derived LT& [2]. This transformation was 
probably catalyzed by the platelet 1Zlipoxygenase 
(12-LO) [3,4]. The lipoxins, including the biologically 
active lipoxin (LX)& and LXB4, are trihydroxylated 
arachidonic acid derivatives, containing a conjugated 
tetraene [l]. They were originally isolated and 
characterized after incubation of human leukocytes, 
possessing high 5-LO activity, with exogenous 
15-H(P)ETE [l]. In accordance, the importance of in- 
teraction between the 5- and 15-lipoxygenases in lipoxin 
formation was postulated. However, the involvement 
of the latter enzyme in lipoxin formation from en- 
dogenous substrate was not convincingly 
demonstrated. Human nasal, tracheal and bronchial 
epithelium possesses high 15-LO activity, with 
15-HETE as the major arachidonic acid metabolite 
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[5-81. Furthermore, 15-HETE has been detected in 
nasal and bronchoalveolar lavage fluid [9,10]. 
Therefore, it was of interest to investigate the capacity 
of tissues derived from the human respiratory tract to 
synthesize lipoxins from synthetic or granulocyte- 
derived LT& . 
The present paper demonstrates that human nasal 
polyps and bronchial tissue convert exogenous LT& to 
LX& and lipoxin isomers. Furthermore, transcellular 
formation of lipoxins & and B4 from endogenous 
substrate in mixed incubations of granulocytes and 
nasal polyps is described. 
2. EXPERIMENTAL 
2.1. Materials 
Arachidonic acid was purchased from Nu-Chek Prep. Inc. (Ely- 
sian, MN, USA). Synthetic LT& methyl ester was from Salford 
Ultrafine Chemicals (Manchester, UK) and was saponified as describ- 
ed [ 111. Ionophore A23187 was obtained from Calbiochem-Behring 
(La Jolla, CA, USA), Dextran T-500 was from Pharmacia Fine 
Chemicals (Uppsala, Sweden) and Lymphoprep from Nyegaard & 
Co. (Oslo, Norway). Fatty acid free human serum albumin was from 
Sigma (St. Louis, MO, USA). Synthetic standard of 5-HETE was a 
kind gift from Dr T. Miyamoto (ON0 Pharmaceutical, Osaka, 
Japan). Biosynthetic standards of IS- and 12-HETE were prepared 
from incubations of arachidonic acid with soybean lipoxygenase 
(Sigma) and human platelets [12], respectively. Synthetic lipoxin 
standards were kindly provided by Dr K.C. Nicolaou (Univ. of 
Penn., PA, USA). 
2.2. Tissue preparation 
Nasal polyp tissue was obtained from patients undergoing nasal 
polypectomies and bronchial tissue was dissected from 
macroscopically normal parts of human lungs derived from patients 
undergoing surgery due to lung carcinoma. The tissues were collected 
within 30 min after surgical removal, kept on ice, chopped with fine 
scissors and carefully rinsed several times in ice-cold phosphate- 
buffered saline (PBS (pH 7.4), 0.9 mM Ca2+) until the buffer was 
macroscopically free of contaminating blood. 
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2.3. Preporotion of granulocytes 
Peripheral blood was collected using vacutainer tubes containing 
7.5% (v/v) 77 mM EDTA. Suspensions of polymorphonuclear 
granulocytes (PMN; purity approx. 88%) were prepared by dextran 
sedimentation, hypotonic ammonium chloride lysis, Lymphoprep 
centrifugation fl3] and resuspension in PBS. 
2.4. Incubation procedures 
Aliquots of chopped tissue (300 mg/ml PBS) were preincubated 
for 5 min at 37OC prior to a 30 min incubation without exogenous 
stimulus or with either leukotriene & (1OpM) or arachidonic acid 
(75 FM) in the presence or absence of ionophore A23187 (5 PM). In 
other experiments polyp tissue was mixed with PMNs (15 x 106 PMN 
and 150 mg tissue (wet wt) per ml), preincubated for 5 min and in- 
cubated with ionophore A23 187 (5 ,&) for 30 min in the absence or 
presence of exogenous arachidonic acid (75 pM). In all experiments 
where lipoxins were analysed, human serum albumin (0.3 mg/ml) 
was added to the incubation rn~~ 1141. incubations were ter- 
minated by addition of 5 vols of ice-cold ethanol. 
2.5. Isolation, identijkation and quantitution of lipoxygenase 
products 
Precipitated material was removed by centrifugation and the super- 
natants were evaporated and dissolved in mobile HPLC phase. 
Analyses of HETEs and Iipoxins were performed on a Nucleosif 
120-3 Crs column (3 x 100 mm; Mach~ey-Nagel, FRG) eluted with 
methanol/water/acetic acid (72:28:0.01, v/v; 0.4 ml/min) and a 
Nova-Pak Cl8 column (3.9 x 100 mm; Waters Ass., Milford, MA, 
USA) eluted with acetonitrile/water/acetic acid (28 : 72 : 0.01, v/v; 
1 ml/min), respectively. On-line product quantitation was performed 
using a computerized Diode Array Spectrophotometer (HP 8451A) 
or a variable wavelength ultraviolet detector (LDC Sp~tromonitor 
HI) connected to an integrator (L~/Milton Roy IC-1OB). Products 
were identified using co-chromatography with synthetic or biosyn- 
thetic standards and ultraviolet spectroscopy. 
3. RESULTS 
3.1. Formation of monohydroxyeicosatetraenoic acids 
Incubation of chopped nasal polyps without ex- 
ogenous stimulus at 37’C for 30 min, led to production 
of l%HETE, while no 12- or 5-HETE was formed. Ad- 
dition of arachidonic acid (75 FM) markedly increased 
the 1%HETE synthesis and induced a minor IZHETE 
production (Figs 1 and 2). Addition of calcium 
ionophore A23 187 (5 ,uM) did not significantly alter the 
HETE formation. Detectable levels of 5-HETE could 
not be observed under any condition. Bronchial tissue 
converted exogenous arachidonic acid to 15-HETE, 
while 5- and 1ZHETE was not formed. Comparison of 
the synthetic capacity showed that bronchial tissue pro- 
duced 7.5 f 5.3 nmol 15-HETE/g tissue (mean 4 SD, 
n = 4) and polyp tissue 37.0 t- 18.4 nmol/g (n = 3) 
after incubation with arachidonic acid and ionophore 
A23187. Neither nasal polyps nor bronchial tissue pro- 
duced detectable amounts of leukotrienes or lipoxins 
under these conditions. 
3.2. Metabolism of exogenous leukotriene A4 
Chopped nasal polyps (Fig. 3A) and bronchial tissue 
converted exogenous LT& (IOgM) to LX&, 6(S)- 
LX& and the all-tram-isomers of Lx94 and LXB4, 
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Fig. 1. RP-HPLC-chromatogram of HETEs formed by chopped 
human nasal polyps incubated with arachidonic acid (75 FM). 
Retention times of HETE standards are indicated. Inset: on-line 
ultraviolet spectrum of biosynthetic 1%HETE. 
while LXB4 was not formed (Table I). Addition of 
ionophore A23187 to the nasal polyps did not 
significantly alter the lipoxin production from ex- 
ogenous LT&. Fig. 4 shows the ultraviolet spectrum 
of Lxko produced by bronchi~ tissue. 
3.3. Ionophore A23187-induced formation of lipoxins 
in co-incubations of human nasal polyps and 
grunuiocytes 
Granulocytes were mixed with chopped nasal polyps 
and the suspension was stimulated with ionophore 
A23187 for 30 min at 37°C. In these incubations both 
LX& and LXB4 were formed from endogenous 
substrate (Table I). The production of lipoxins increas- 
ed about 3-fold in the presence of exogenous 
arachidonic acid (Table I, Fig. 3B). Granulocytes alone 
produced undetectable or trace amounts of lipoxins. 
40 -I 
Unstimulated A231 87 Aracbidonic acid 
Fig. 2. Formation of 15-HETE (filled bars) and 12-HETE (hatched 
bars) in suspensions of chopped human nasal polyps without stimulus 
or in the presence of ionophore A23187 (5 FM) or arachidonic acid 
(75 FM). Bach value represents the mean f SD of five to six duplicate 
experiments. 
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Fig. 3. RP HPLC-chromatograms of lipoxins formed in (A) suspensions of chopped nasal polyps incubated with LT& (10pM) or (B) mixed 
suspensions of chopped nasal polyps and granuiocytes incubated with ionophore A23187 (5 FM) and arachidonic acid (75 PM). Retention times 
of authentic lipoxin standards are indicated. Inset: on-line ultraviolet spectra of bios~thetic (A) LXA4 and (B) LXB4. 
4. DISCUSSION 
In the present report, we demonstrate that human 
nasal polyps possess considerable 1 Mpoxygenase ac- 
tivity and a capacity to transform authentic or 
granulocyte-derived LT& to lipoxins. Similar results 
were obtained using human bronchial tissue, although 
the capacity of this tissue to convert exogenous LT& 
to lipoxins was markedly lower and paralleled by a less 
pronounced &LO activity. This is in agreement with 
a reported decrease in immuno-rea~ive lipoxygenase 
along the human airways [15]. 
No detectable amounts of 5-HETE or leukotrienes 
were observed after incubation of nasal polyps or bron- 
chia1 tissue with arachidonic acid and ionophore 
A23187, excluding the presence of significant amounts 
of contaminating leukocytes in the tissue preparations. 
Table I 
Formation of lipoxins in human nasal polyps and bronchial tissue 
Incubation conditions Lipoxin A4 Lipoxin B4 
(pmol/g tissue) (pmol/g tissue) 
Nasal polyps + LT& (10 ,uM) 336 f 108 n.d. 
Nasal polyps + LT& + A23187 
(5 rM) 305 * 113 n.d. 
Nasal polyps + PMN + A23187 look 30 70 f 24 
Nasal polyps + PMN + 
A23 187 + AA (75 ,uM) 364 f 131 151 4 32 
Bronchial tissue + LT& + 
A23187 84 f 96 n.d. 
Aliquots of 300 mg tissue/ml (wet weight) or 15 x 10e PMN and 
150 mg tissue/ml were incubated at 37°C for 30 min in the presence 
of various stimuli as indicated. Products were identified and 
quantified as described in section 2. Data are presented as mean i SD 
of 5-6 duplicate experiments. AA, arachidonic acid; nd., not 
detected 
Small amounts of 1ZHETE were formed after incuba- 
tion of nasal polyps with exogenous arachidonic acid. 
However, although this may suggest a minor platelet 
contamination, platelets were probably not responsible 
for the conversion of LT& to Iipoxins in suspensions 
of chopped nasal polyps, since this conversion was 
unaffected by ionophore A23187. In contrast, forma- 
tion of lipoxins by human platelets is markedly 
stimulated by addition of the ionophore [2]_ Neither 
did the ionophore stimuIate 15HETE formation from 
endogenous or exogenous arachidonic acid by the 
polyps. The results suggest the involvement of an 
epithelial 15-LO (possibly also possessing minor 12-LO 
activity) in the production of lipoxins by airway tissue. 
Transcellular lipoxin formation in mixed 
granuloc~e/nas~ polyp incubations probably involves 
at least two pathways. First, LT&, synthesized by the 
granulocyte 5-LO, may be released and further con- 
verted to the putative tetraene intermediate 5(6)- 
epoxy-Whydroxyeicosatetraenoic acid [16] by the 
- 260 340 
(nm) 
Fig. 4. Ultraviolet spectrum of LxA4 formed by human bronchial 
tissue after incubation with exogenous LT& (10 FM) and ionophore 
A23187 (5 yM). 
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1%LO in the polyp tissue. ~ub~~uently, this in- 
termediate may be hydrolysed to the trihydr~xy~ated 
lipoxins. This hypothesis is supported by the finding 
that nasal polyps transformed synthetic LTkr to lipox- 
ins. Second, l$H(P)ETE, synthesized by the polyp 
tissue, may be further converted to the tetraene-epoxide 
interme~ate by the granuIoqt.e S-LO [I]. The finding 
that nasal polyps produced 15HETE and that the for- 
mation of this compound was markedly increased in 
the presence of exogenous arachidonic acid, which was 
also true for the lipoxin formation in mixed 
~anulo~~e/~as~ polyp incubations~ supports the pro- 
posed second route of formation. 
Lipoxin B4 formation was observed exxdusively in the 
presence of granulocytes. These findings are in agree- 
ment with the results obtained with incubations of mix- 
ed platelets-granuiocytes [2,4], indicating the 
involvement of a ~an~oc~e~e~ndent epoxide 
hydrolase activity in LX% formation. 
We have previously reported production of lipoxins 
via platelet-dependent lipoxygenation at C-15 of 
granulocyte-derived LT& [a]. The present results fur- 
ther indicate a role for LT& as a key intermediate in 
lipoxin synthesis. In addition, the irn~rt~~e of U-LO 
in the formation of fipoxins in human respiratory tissue 
is demonstrated. During pathophysiological condi- 
tions, epithelial cells or other extravascular cells 
possessing 1 Mipoxygenase activity, may synthesize 
lipoxins in cooperation with activated leukocytes. Since 
LX&, afthough being a weak in~~rnato~ agonist 
fl], has been reported to be a more powerful antagonist 
of LTB4- and LTD4-induced biological effects [ 17-19], 
transcellular lipoxin formation may be of importance 
for regulation of inflammatory reactions in the 
airways. 
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